151 related articles for article (PubMed ID: 9137907)
1. Pharmacology and regulation of the neuronal dopamine transporter.
Reith ME; Xu C; Chen NH
Eur J Pharmacol; 1997 Apr; 324(1):1-10. PubMed ID: 9137907
[TBL] [Abstract][Full Text] [Related]
2. Chronic and acute regulation of Na+/Cl- -dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems.
Zahniser NR; Doolen S
Pharmacol Ther; 2001 Oct; 92(1):21-55. PubMed ID: 11750035
[TBL] [Abstract][Full Text] [Related]
3. The dopamine transporter in mesencephalic cultures is refractory to physiological changes in membrane voltage.
Prasad BM; Amara SG
J Neurosci; 2001 Oct; 21(19):7561-7. PubMed ID: 11567046
[TBL] [Abstract][Full Text] [Related]
4. Cocaine inhibits NGF-induced PC12 cells differentiation through D(1)-type dopamine receptors.
Zachor DA; Moore JF; Brezausek C; Theibert A; Percy AK
Brain Res; 2000 Jun; 869(1-2):85-97. PubMed ID: 10865062
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of the dopamine transporter.
Giros B; Caron MG
Trends Pharmacol Sci; 1993 Feb; 14(2):43-9. PubMed ID: 8480373
[TBL] [Abstract][Full Text] [Related]
6. Methamphetamine-induced alterations in dopamine transporter function.
Bennett BA; Hollingsworth CK; Martin RS; Harp JJ
Brain Res; 1998 Jan; 782(1-2):219-27. PubMed ID: 9519266
[TBL] [Abstract][Full Text] [Related]
7. Early administration of tiapride to young rats without long-lasting changes in the development of the dopaminergic system.
Bock N; Moll GH; Wicker M; Pilz J; Rüther E; Banaschewski T; Huether G; Rothenberger A
Pharmacopsychiatry; 2004 Jul; 37(4):163-7. PubMed ID: 15467972
[TBL] [Abstract][Full Text] [Related]
8. Molecular, functional and biochemical characteristics of the dopamine transporter: regional differences and clinical relevance.
Hitri A; Hurd YL; Wyatt RJ; Deutsch SI
Clin Neuropharmacol; 1994 Feb; 17(1):1-22. PubMed ID: 8149355
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
[TBL] [Abstract][Full Text] [Related]
10. Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat.
Kimmel HL; Joyce AR; Carroll FI; Kuhar MJ
J Pharmacol Exp Ther; 2001 Jul; 298(1):129-40. PubMed ID: 11408534
[TBL] [Abstract][Full Text] [Related]
11. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding.
Rothman RB; Dersch CM; Carroll FI; Ananthan S
Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522
[TBL] [Abstract][Full Text] [Related]
12. Evidence that pure uptake inhibitors including cocaine interact slowly with the dopamine neuronal carrier.
Héron C; Costentin J; Bonnet JJ
Eur J Pharmacol; 1994 Nov; 264(3):391-8. PubMed ID: 7698180
[TBL] [Abstract][Full Text] [Related]
13. Brain dopamine transporter: gender differences and effect of chronic haloperidol.
Rivest R; Falardeau P; Di Paolo T
Brain Res; 1995 Sep; 692(1-2):269-72. PubMed ID: 8548314
[TBL] [Abstract][Full Text] [Related]
14. In vivo measures of dopaminergic radioligands in the rat brain: equilibrium infusion studies.
Kilbourn MR; Sherman PS; Kuszpit K
Synapse; 2002 Mar; 43(3):188-94. PubMed ID: 11793424
[TBL] [Abstract][Full Text] [Related]
15. Binding of the cocaine analog 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane to serotonin and dopamine transporters: different ionic requirements for substrate and 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane binding.
Wall SC; Innis RB; Rudnick G
Mol Pharmacol; 1993 Feb; 43(2):264-70. PubMed ID: 8429827
[TBL] [Abstract][Full Text] [Related]
16. Dopamine transporter mutants selectively enhance MPP+ transport.
Kitayama S; Wang JB; Uhl GR
Synapse; 1993 Sep; 15(1):58-62. PubMed ID: 8310426
[TBL] [Abstract][Full Text] [Related]
17. The antidepressant-sensitive dopamine transporter in Drosophila melanogaster: a primordial carrier for catecholamines.
Pörzgen P; Park SK; Hirsh J; Sonders MS; Amara SG
Mol Pharmacol; 2001 Jan; 59(1):83-95. PubMed ID: 11125028
[TBL] [Abstract][Full Text] [Related]
18. Structure and function of the dopamine transporter.
Chen N; Reith ME
Eur J Pharmacol; 2000 Sep; 405(1-3):329-39. PubMed ID: 11033338
[TBL] [Abstract][Full Text] [Related]
19. Release of dopamine via the human transporter.
Eshleman AJ; Henningsen RA; Neve KA; Janowsky A
Mol Pharmacol; 1994 Feb; 45(2):312-6. PubMed ID: 7906856
[TBL] [Abstract][Full Text] [Related]
20. What can be learned from studies of multisubstrate mechanisms of neuronal dopamine transport?
Schenk JO; George SE; Schumacher PD
Eur J Pharmacol; 2003 Oct; 479(1-3):223-8. PubMed ID: 14612152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
